You are here: Industry Insights > COVID-19

News List

Mylan and Gilead waive exclusivity for potential Covid-19 therapies pharmaceutical-technology
March 27, 2020
Mylan has waived its exclusive rights to generic Kaletra (lopinavir / ritonavir) in the US to aid wider access in case the medication would be effective Covid-19 therapies.
Xencor, Vir Biotechnology sign licensing deal for Covid-19 pharmaceutical-technology
March 27, 2020
Biopharmaceutical firm Xencor has entered into a technology licence agreement with Vir Biotechnology providing the latter with non-exclusive access to Xtend Fc technology.
Sorrento Therapeutics to develop cellular vaccine for Covid-19 pharmaceutical-technology
March 27, 2020
Sorrento Therapeutics has started a programme to develop a decoy cellular vaccine, STI-6991, against Covid-19 coronavirus infection.
Medicago announces production of a viable vaccine candidate for COVID-19 expresspharma
March 27, 2020
The biopharma successfully produced Virus-Like Particles (VLP) of the coronavirus in just 20 days using proprietary plant-based technology Medicago’s platform can produce both vaccine and antibody candidates against COVID-19 disease.
‘Nearly 70 drugs that may be effective against coronavirus identified’ expresspharma
March 27, 2020
An international team, including scientists of Indian origin, has identified 69 drugs and experimental compounds which may be effective in treating COVID-19.
COVID-19: AstraZeneca to distribute masks as ASCO goes virtual pharmatimes
March 26, 2020
As of this morning - Wednesday 25th March - the current recorded case count for COVID-19 (coronavirus) in the UK has hit 8,077, with 422 deaths and 135 recoveries.
The FDA is facilitating access to convalescent plasma collected from recovered COVID-19 patients worldpharmanews
March 26, 2020
The FDA is facilitating access to convalescent plasma, antibody-rich blood products that are taken from blood donated by people who have recovered from the COVID-19 virus.
Singapore modelling study estimates impact of physical distancing on reducing spread of COVID-19 worldpharmanews
March 26, 2020
A new modelling study conducted in a simulated Singapore setting has estimated that a combined approach of physical distancing [2] interventions ...
Mesa Biotech Receives Emergency Use Authorization for 30 Minute COVID-19 Test americanpharmaceuticalreview
March 26, 2020
Mesa Biotech announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for its Accula™ SARS-CoV-2 Test.
Ampio Preparing Expanded Access FDA Protocol to Study Ampion for Severe COVID-19 ARDS americanpharmaceuticalreview
March 26, 2020
Ampio Pharmaceuticals is preparing an expanded access FDA protocol to study potential benefit of nebulized treatment with Ampion in SARS-Cov-2 (COVID-19) induced Acute Respiratory Distress Syndrome (ARDS).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page